You are here
Shire to buy rare-disease drugmaker NPS Pharmaceuticals for US$5.2b
SHIRE plc, the drugmaker seeking to boost growth after its proposed sale to AbbVie Inc collapsed, agreed to buy NPS Pharmaceuticals Inc for about US$5.2 billion to add medicines used to treat rare diseases.
Shire will pay US$46 a share in cash, the Dublin-based company said
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org